PatientsLikeMe ™

PD
Skip over navigation
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Eldepryl, Emsam, Zelapar

What is Selegiline? Selegiline is a MAO-B inhibitor which slows the breakdown of l-dopa. Used in combination with l-dopa containing drugs such as Sinemet it can improve their efficacy. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

135 patients in the community are taking or have taken Selegiline.

Reason # Patients Percentage of patients
Treat Parkinson's 102 75%
Stiffness/spasticity 7 5%
Other 5 3%
disease-related symptoms 4 2%
Support another treatment 2 1%
Dry mouth (xerostomia) 1 <1%
Hand tremor 1 <1%
Slowness 1 <1%
Excessive daytime sleepiness (somnolence) 1 <1%
Fatigue 1 <1%
Depression 1 <1%

Dosages

Based on the patients currently taking Selegiline.

Top 10 (Show all)

All (Show Top 10)

  0 mg day 0 mg none 0.1 mg day 0.5 mg day 1.25 mg day 1.5 mg day 1.5 day 2.25 mg day 2.5 mg day 3 mg day 5 mg day 5 mg none 6 mg day 10 mg day 15 mg day 20 mg day 40 mg day 125 mg day
  9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 13 Number of Patients: 13 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 10 Number of Patients: 10 1 Number of Patients: 1 13 Number of Patients: 13 1 Number of Patients: 1 1 Number of Patients: 1 37 Number of Patients: 37 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Selegiline or how long patients were taking Selegiline before stopping.

Currently taking Selegiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
4
7
15
15
25

Stopped taking Selegiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
6
2
5
3
5
15
Why Patients Stopped Taking Selegiline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 10 26% Doctor's advice: 26%
Did not seem to work 9 24% Did not seem to work: 24%
Side effects too severe 9 24% Side effects too severe: 24%
Other 8 21% Other: 21%
Personal research 5 13% Personal research: 13%
Not indicated 2 5% Not indicated: 5%
Expense 1 3% Expense: 3%
Course of treatment ended 1 3% Course of treatment ended: 3%

Patient Reported Evaluations

Results from 10 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 29% 2
Moderate 29% 2
Slight 29% 2
Can't tell 14% 1

Treat Parkinson's

Side-effects (as an overall problem)

Severe 20% 2
Moderate 10% 1
Mild 10% 1
None 60% 6

Top reported side-effects include: trouble falling asleep, tiredness, Psychosis

Summary results are based on 10 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 10)

  • EfficacyCan't tell
  • Side-effectsNone
  • Treat Parkinson's

  • EfficacyModerate
  • Side-effectsNone
  • Depression
Advice/Tips
stick with it

See all evaluation results for Selegiline



Back to top